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The retinoblastoma-like protein p130 is involved in the
determination of reserve cells in differentiating myoblasts
Gilles Carnac*, LLuis Fajas†, Aurore L’honoré*, Claude Sardet†,
Ned J.C. Lamb* and Anne Fernandez* 
During skeletal muscle differentiation, a subset of
myoblasts remains quiescent and undifferentiated but
retains the capacity to self-renew and give rise to
differentiating myoblasts [1–3]: this sub-population of
muscle cells was recently termed ‘reserve cells’ [3]. In
order to characterise genes that can regulate the ratio
between reserve cells and differentiating myoblasts, we
examined members of the retinoblastoma tumor
suppressor family — Rb, p107 and p130 — an important
family of negative regulators of E2F transcription
factors and cell cycle progression [4]. Although pRb and
p107 positively regulate muscle cell differentiation
[5–7], the role of p130 in muscle cells remains unknown.
We show here that p130 (protein and mRNA), but
neither pRb nor p107, preferentially accumulates during
muscle differentiation in reserve cells. Also, p130 is the
major Rb-family protein present in E2F complexes in
this sub-population of cells. Although forced expression
of either p130 or pRb in mouse C2 myoblasts efficiently
blocked cell cycle progression, only p130 inhibited the
differentiation program. Furthermore, muscle cells
overexpressing p130 had reduced levels of the muscle-
promoting factor MyoD. In addition, p130 repressed the
transactivation capacity of MyoD, an effect abolished by
co-transfection of pRb. Thus, we propose that p130, by
blocking cell cycle progression and differentiation,
could be part of a specific pathway that defines a pool
of reserve cells during terminal differentiation.
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Results and discussion
p130 expression is mainly confined to reserve cells
We previously showed [1] that a short and mild trypsinisa-
tion of cultured differentiated myoblasts removes most
myotubes, leaving only undifferentiated residual cells, the
reserve cells, which remain adherent to culture dishes
(Figure 1a). Western blot analysis of pRb, p107 and p130
in proliferating myoblasts, myotubes and reserve cells
showed that pRb was found in both hyper- and hypo-
phosphorylated forms in growing myoblasts (Figure 1a). It
was also present in reserve cells and in myotubes, but only
in a hypo-phosphorylated form. p107 was present at high
levels in proliferating myoblasts and its expression
dropped to undetectable levels as differentiation pro-
ceeded. p130 was expressed at low levels in myoblasts and
at increased levels in differentiated cells but clearly, this
p130 upregulation mainly occurred in reserve cells. As we
previously reported, Myf-5 was detectable only in reserve
cells, whereas MyoD became restricted to myotubes as
differentiation proceeded. Troponin T, a marker of differ-
entiation, was present only in myotubes, demonstrating
that reserve cells and myotubes had been correctly sepa-
rated (Figure 1a). To determine whether up-regulation of
p130 protein was accompanied by an increase in p130
mRNA, we performed a northern blot analysis. The level
of p130 mRNA was low in proliferating myoblasts and dra-
matically increased (3–4-fold) in reserve cells (Figure 1b).
Myf-5 mRNA levels were the same in proliferative and
reserve cells and it was totally absent from myotubes.
MLC1A, a marker of differentiation, was mainly restricted
to the myotube fraction (Figure 1b). Therefore, the
changes in the pool of p130 protein appeared to parallel
the fluctuations in p130 mRNA level, suggesting that
Figure 1
Up-regulation of p130 expression during muscle differentiation is mainly
restricted to reserve cells. C2.7 cells were grown for 2 days in
proliferative conditions and then switched to low serum-containing
medium for 4 days to induce the differentiation program. (a) Western
blot analysis; (b) northern blot analysis. P, proliferative C2 myoblasts;
R, reserve cells; M, myotubes; Trop.T, troponin T; Tub, tubulin. Tubulin
and S26 are loading controls.
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p130 accumulation in the pool of reserve cells is most
likely due to transcriptional activation of the p130 gene.
p130 is associated with E2F in reserve cells
The transcription factor E2F plays a critical role in cell
growth control and is a potential target of Rb-related pro-
teins [4]. To determine whether p130 is associated with
E2F protein in reserve cells, we performed a standard elec-
trophoretic mobility shift assay (EMSA) to detect com-
plexes with E2F-like properties in reserve and myotube
cell extracts. Specific binding of a protein complex to the
MLC1A CArG box [8] was detected in myotubes but not in
reserve cells (Figure 2a), indicating that the different sub-
populations of cells had been correctly isolated. These two
subpopulations contained one major E2F-like DNA-
binding activity (Figure 2b), which was highly represented
in reserve cells. The binding specificity of this complex was
confirmed using mutated E2F-binding oligonucleotides. In
reserve cells and to a lesser extent in myotubes, addition of
an anti-p130 antibody resulted in conversion of the upper
complex to a supershifted complex (Figure 2c), whereas
pRb or p107 antibodies did not supershift the complex, as
previously reported [9,10]. Taken together, our results indi-
cate that p130 is the main retinoblastoma-family linked to
the E2F complex in reserve cells.
p130 prevents cell cycle progression and differentiation of
mouse C2 myoblasts
To determine whether p130 upregulation is crucial for
keeping reserve cells in an undifferentiated quiescent
stage, we overexpressed p130 in myoblasts (which contain
low levels of endogenous p130) and examined the effect of
such forced expression on cell proliferation and differentia-
tion by co-immunofluorescence analysis. For comparison,
the same experiment was carried out with pRb. C2
myoblasts were transiently transfected with plasmids
encoding HA-tagged constructs of p130 or pRb, or encod-
ing b -galactosidase driven by the cytomegalovirus pro-
moter (CMV–b -gal) as a control, and were pulse-labelled
with bromo-deoxyuridine (BrdU) to monitor cells undergo-
ing S phase. As shown in Figure 3a and Table 1, most cells
expressing either pRb or p130 failed to incorporate BrdU,
showing that they were blocked before S phase entry. In
contrast, cells overexpressing b -gal frequently showed co-
immunostaining for BrdU, indicating that transfected
DNA had no major effect on muscle cell proliferation.
To evaluate the impact of p130 on early phases of differ-
entiation, we transiently overexpressed HA–p130 and
HA–pRb in C2 myoblasts. Cells were then placed in low
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Figure 2
p130 is the prominent component of the E2F complex in reserve cells.
EMSA, used to detect proteins that bind to (a) the MLC1a CArG box
and (b,c) the E2F-binding site from the adenovirus E2 promoter, was
performed essentially as described in [21]. (c) For EMSA supershift
experiments, antibodies were added to the reaction as indicated.
WT, wild-type DNA; mut, mutant DNA; P, proliferating myoblasts;
R, reserve cells; M, myotubes.
Figure 3
Overexpression of p130 blocks both muscle
cell proliferation and differentiation. Mouse
C2 myoblasts were transfected with
CMV– b -gal, CMV–HA–p130 or HA–pRb
expressed from the plasmid pECE. (a) At
24 h after transfection, BrdU was added to
C2 cultures for 24 h and cells were then
processed for co-immunofluorescence
analysis using antibodies directed against
BrdU to detect DNA synthesis (left panels)
and b -gal or HA tag to detect overexpressed
proteins (middle panels). Cell nuclei were
revealed by staining for DNA with Hoechst
(right panels). (b) At 6 h after transfection,
cells were switched to low serum-containing
medium for 48 h and co-immunofluorescence
analysis was then performed using antibodies
to HA (left panels) or myogenin (to probe for
differentiation; middle panels). Cell nuclei
were revealed by staining for DNA with
Hoechst (right panels). Open arrows indicate
co-staining, i.e. no inhibition of proliferation or
differentiation; filled arrows indicate staining
with anti-HA but not anti-myogenin, i.e.
blocked proliferation or differentiation. The
scale bar represents 10m m.
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serum-containing medium to induce differentiation. Over-
expression of pRb did not significantly inhibit the process
of differentiation, as 90% of HA-positive cells expressed
the differentiation marker myogenin (Figure 3b, lower
panels). In contrast, over 90% of HA–p130 positive cells
were negative for myogenin staining, indicating that p130
clearly inhibited differentiation (Figure 3b, lower panels).
Therefore, even though forced expression of pRb and
p130 both blocked muscle cell proliferation with similar
efficiency, only p130 actively prevented their differentia-
tion (see Table 1).
p130 inhibits MyoD expression and its ability to
transactivate muscle genes
In many myogenic cell lines, the capacity of cells to differen-
tiate appears to be linked to the level of MyoD expression
[11]. To test whether p130 can regulate the expression of
MyoD, C2 cells were transiently transfected with HA–p130
or HA–pRb and then analysed by immunofluorescence
analysis for MyoD and HA tag expression. Figure 4a shows
that ectopic expression of p130 strongly reduced MyoD
protein levels: only 10% of HA–p130-positive cells expressed
MyoD (upper panels). In contrast, 90% of pRb expressing
cells presented normal levels of MyoD protein (Figure 4a,
lower panels; see also Table 1). Because MyoD can activate
its own expression [12], we asked whether p130 prevented
MyoD expression by interfering with its transcriptional activ-
ity. To assess potential regulation of MyoD transactivation
capacities by p130, we used a standard transcriptional assay.
A construct containing the promoter of muscle creatine
kinase driving luciferase expression (MCK–luc) was used as
a reporter gene for MyoD activity. When transfected into
mouse 10T1/2 fibroblasts, the MCK promoter had a low
level of activity that increased up to threefold upon co-trans-
fection of MyoD (Figure 4b). Co-expression of p130, but not
pRb, resulted in a marked inhibition of MyoD-dependent
activation of MCK–luc. Interestingly, overexpression of pRb
together with p130 relieved this p130-dependent inhibition
of MyoD activity. Therefore, we postulate that inhibition on
MyoD gene expression and protein activity by p130 is
responsible for the negative control imposed by p130 on
muscle cell differentiation.
Stem-cell-like subpopulation of muscle precursors in vitro
In this report, we have identified a new marker expressed
in reserve cells, the Rb-related protein p130, which, by
inhibiting both cell proliferation and differentiation, may
participate in the establishment of reserve-cell properties.
Another gene previously shown to be specifically expressed
in reserve cells was Myf-5, a member of MyoD gene family
[1–3]. It is puzzling to detect a muscle-promoting factor in
cells that failed to differentiate unless the role of Myf-5 is
to maintain muscle commitment in such cells. Recently,
Dominov et al. [13] reported that Bcl-2, an apoptosis-
inhibiting protein, is expressed by myoblasts and persists in
reserve cells. It appears to participate in clonal expansion of
myogenic cells by protecting them from apoptosis. In the
literature, there have been a number of reports of induction
of proteins in mature skeletal muscle that paradoxically
induce cell cycle arrest but block differentiation [14,15]. In
light of our results, we postulate that these inhibitory pro-
teins might be specifically induced in reserve cells and, in
conjunction with Myf-5, Bcl-2 and p130, could function as a
binary switch that would determine whether cells progress
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Table 1
Effect of forced expression of p130 and Rb on C2 myoblast
proliferation and differentiation.
Cells (%) positive for:
BrdU Myogenin MyoD
b -gal 70 (n = 120) n.d. n.d.
HA–Rb 10 (n = 128) 90 (n = 220) 90 (n = 165)
HA–p130 10 (n = 133) 5 (n = 150) 5 (n = 138)
Summary of quantification for BrdU incorporation, myogenin and MyoD
expression in C2 cells overexpressing CMV–b -gal, CMV–HA–p130 or
pECE–HA–pRb (see Figures 3,4a). n.d., not determined.
Figure 4
Overexpression of p130 inhibits MyoD expression and protein activity.
(a) C2 myoblasts were transfected with either CMV–HA–p130 or
pECE–HA–pRb. At 6 h after transfection, cells were switched to
low-serum-containing medium for 48 h. Cells were then processed for
co-immunofluorescence analysis using antibodies directed against HA
(left panels) and MyoD (middle panels). Nuclei were revealed by staining
for with Hoechst (right panels). Open arrows indicate co-staining, i.e. no
inhibition of proliferation or differentiation; filled arrows indicate staining
with anti-HA but not anti-myogenin, i.e. blocked proliferation or
differentiation. The scale bar represents 10 m m. (b) 10T1/2 cells were
tranfected with MCK–luc together with plasmids expressing the indicated
proteins or a control vector (PEMSV). Cells were grown for 48 h in
differentiation medium and then harvested for the luciferase assay. Values
plotted for experiments 1 and 2 are mean values of duplicate dishes.
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into the differentiation pathway or commit to the stem-cell-
like subpopulation of muscle precursors.
p130, the cell cycle and differentiation
We and others [1–3] showed that, upon entry into differen-
tiation, MyoD expression is restricted to myoblasts commit-
ted to differentiate and therefore absent from reserve cells.
Yoshida et al. [3] suggested that downregulation of MyoD is
a causal event in the formation of reserve cells. Therefore,
high levels of p130 in reserve cells might be required to
directly block MyoD expression and activity. Alternatively,
p130 might block myoblasts in a phase of the cell cycle that
is not permissive for MyoD activity. Consistent with this
hypothesis, we have previously shown that MyoD is absent
from G0-synchronised myoblasts [1]. The observation that
in non-muscle cells, the formation of an E2F–p130 complex
is unique to cells in G0 stage [16] reinforces our previous
hypothesis [1] that myoblasts exit into differentiation at a
point in G1 distinct from this G0-quiescent state typical of
reserve cells. Unlike p130, pRb enhances MyoD activity
and, as shown here, relieves p130 inhibition of MyoD activ-
ity. The biochemical basis of this Rb/p130 functional oppo-
sition remains unclear, because Rb appears to promote
muscle differentiation through various mechanisms includ-
ing direct physical interaction with MyoD [5], cooperation
with MyoD to induce MEF2A transcriptional activity [17]
and/or modulation of Ras activity [18].
Given that increased p130 expression is incompatible with
differentiation, it is puzzling to detect significant levels of
p130 protein in myotubes complexed to E2F. However, we
postulate that this fraction of protein can be inactivated as
differentiation proceeds and/or the myogenic inhibitory
effect of p130 is distinct from its ability to bind E2F. This
last hypothesis is reinforced by recent observations realised
on pRb. Using various Rb mutant proteins, Sellers et al. [19]
found that binding of pRb to E2F is required for pRb to
induce acute G1/S block but not for it to promote induction
of differentiation. This would imply that the differentia-
tion-blocking activity of p130 lies in a region of p130 dis-
tinct from its pocket domain (a region highly homologous
between Rb and p130 and involved in binding to E2F).
Mice lacking the p130 gene showed varying degrees of
tissue disorganisation and, notably, a reduced number of
skeletal muscle cells [20]. This phenotype is difficult to
interpret, as tissues adjacent to myotome known to have a
positive influence on muscle cell behaviour, such as the
neural tube, are also deeply affected. In the light of our
results, however, it appears consistent that inactivation of
p130, by reducing the pool of reserve cells, will lead to
fewer skeletal muscle fibres. 
Supplementary material
Supplementary material including additional methodological details is
available at http://current-biology.com/supmat/supmatin.htm.
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